KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Sarepta Therapeutics (SRPT) Long-Term Debt Issuances (2015 - 2018)

Sarepta Therapeutics' quarterly Long-Term Debt Issuances came in at $18.2 million in Q4 2018, up 79.92% year-on-year from $10.1 million in Q4 2017, and down 59.09% quarter-over-quarter from $44.4 million in Q3 2018.

Sarepta Therapeutics has reported Long-Term Debt Issuances for 3 years, with the latest figure at $18.2 million in Q4 2018.

  • For the quarter ending Q4 2018, Long-Term Debt Issuances rose 79.92% year-over-year to $18.2 million; the trailing twelve-month figure through Dec 2023 stood at $18.2 million (down 70.97% YoY), and the FY2022 full-year result was $1.1 billion, changed N/A from the prior year.
  • Long-Term Debt Issuances for Q4 2018 stood at $18.2 million, down from $44.4 million in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $96.2 million in Q1 2018, with the low at -$133000.0 in Q3 2015.
  • Average Long-Term Debt Issuances over 3 years is $35.2 million, with a median of $18.2 million recorded in 2018.
  • Peak annual rise in Long-Term Debt Issuances reached 79.92% in 2018, while the deepest fall reached 79.92% in 2018.
  • Tracing SRPT's Long-Term Debt Issuances over 3 years: stood at $399000.0 in 2015, then soared by 2428.32% to $10.1 million in 2017, then jumped by 79.92% to $18.2 million in 2018.
  • The last three Long-Term Debt Issuances figures came in at $18.2 million (Q4 2018), $44.4 million (Q3 2018), and $77.1 million (Q2 2018), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 2.73 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Sarepta Therapeutics 1.86 Bn 1.17 Bn 291.52 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2018 18.15 Mn
Dec 31, 2018 18.15 Mn
Sep 30, 2018 44.37 Mn
Sep 30, 2018 44.37 Mn
Jun 30, 2018 77.12 Mn
Jun 30, 2018 77.12 Mn
Mar 31, 2018 96.24 Mn
Mar 31, 2018 96.24 Mn
Dec 31, 2017 10.09 Mn
Dec 31, 2017 10.09 Mn
Dec 31, 2015 399,000.00
Dec 31, 2015 399,000.00
Sep 30, 2015 -133,000.00
Sep 30, 2015 -133,000.00